Quantifying the pathology of neurodegenerative disorders: Quantitative measurements, sampling strategies and data analysis

Histopathology

Volumn 42, Issue 6, 2003, Pages 521-529

  Armstrong, R A ^a  

^a ASTON UNIVERSITY   (United Kingdom)

Author keywords

Abundance; Alzheimer's disease; Dementia with Lewy bodies; Neurodegenerative disorders; Quantitative measurements; Sampling methods

Indexed keywords

ALZHEIMER DISEASE; ANALYSIS OF VARIANCE; DATA ANALYSIS; DEGENERATIVE DISEASE; DEMENTIA WITH LEWY BODY; DENSITY; DIFFUSE LEWY BODY DISEASE; HUMAN; MASS; MEASUREMENT; NEUROPATHOLOGY; PRINCIPAL COMPONENT ANALYSIS; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REVIEW; SAMPLING;

ALZHEIMER DISEASE; HUMANS; NEURODEGENERATIVE DISEASES; PATHOLOGY; SAMPLE SIZE; STATISTICS;

EID: 0037495279     PISSN: 03090167     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2559.2003.01601.x     Document Type: Review

References (51)

1. Armstrong RA. The spatial patterns of β-amyloid deposits and neurofibrillary tangles in the cerebral cortex in Alzheimer's disease. Alz. Report 2000: 3; 133-141.
2. Bruce CV, Clinton J, Gentleman SM, Roberts GW, Royston MC. Quantifying the pattern of β/A4 amyloid protein distribution in Alzheimer's disease by image analysis. Neuropathol. Appl. Neurobiol. 1992; 18; 125-136.
3. MacDonald ST, Sutherland K, Ironside JW. A quantitative and qualitative analysis of prion protein immunohistochemical staining in Creutzfeldt-Jakob disease using four anti-prion protein antibodies. Neurodegen. 1996: 5; 87-94.
4. Syed AB, Armstrong RA, Smith CUM. Quantification of axonal loss in Alzheimer's disease: an image analysis study. Alz. Report 2000; 3: 19-24.
5. Mattfeldt T, Frey H, Rose C. Second-order stereology of benign and malignant alterations of the human mammary gland. J. Microscopy 1993: 171; 143-151.
6. Reed MG, Howard CV. Stereological estimation of covariance using linear dipole probes. J. Microscopy 1999: 195; 96-103.
7. Mayhew TM. 3D structure from thin sections: applications of stereology. Microscopy Anal. 2000; 80; 7-10.
8. Armstrong RA, Lantos PL, Cairns NJ. What does the study of spatial patterns of pathological lesions tell us about the pathogenesis of neurodegenerative disorders? Neuropathology 2001: 21; 1-12.
9. Delaere P, Duykaerts C, He Y, Piette F, Hauw JJ. Subtypes and differential laminar distribution of β/A4 deposits in Alzheimer's disease: relationship with the intellectual status of 26 cases. Acta Neuropathol. 1991: 81: 328-335.
10. Armstrong RA. The spatial patterns of β/A4 deposit subtypes in Down's syndrome. Acta Neuropathol. 1994: 88; 353-358.
11. Watanabe R, Duchen LW. Cerebral amyloid in human prion disease. Neuropathol. Appl. Neurobiol. 1993: 19: 253-260.
12. Parchi P, Giese A. Capellari S et al. Classification of sporadic Creutzfeldt-Jakob disease based on molecular and phenotypic analysis of 300 subjects. Ann. Neurol. 1999: 46; 224-233.
13. Armstrong RA. Is the clustering of neurofibrillary tangles in Alzheimer's patients related to the cells of origin of specific cortico-cortical projections? Neurosci. Lett. 1993; 160; 57-60.
14. McKeith IG, Galasko D. Kosaka K et al. Consensus guidelines for the clinical and pathological diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop. Neurology 1996: 47: 1113-1124.
15. Armstrong RA, Cairns NJ, Lantos PL. Dementia with Lewy bodies: clustering of Lewy bodies in human patients. Neurosci. Lett. 1997: 224; 41-44.
16. Hof PR, Bouras C, Perl DP, Morrison JH. Quantitative neuropathological analysis of Pick's disease cases: cortical distribution of Pick bodies and coexistence with Alzheimer's disease. Acta Neuropathol. 1994: 87; 115-124.
17. Armstrong RA, Cairns NJ, Lantos PL. Clustering of Pick bodies in patients with Pick's disease. Neurosci. Lett. 1998; 242; 81-84.
18. Ikeda K. Basic pathology of corticobasal degeneration. Neuropathol. 1997: 17; 127-133.
19. Mori H, Oda M. Ballooned neurons in corticobasal degeneration and progressive supranuclear palsy. Neuropathol. 1997: 17: 248-252.
20. Jackson M, Lowe J. The new neuropathology of degenerative frontotemporal dementias. Acta Neuropathol. 1996: 91; 127-134.
21. Mirra SS, Heyman A, McKeel D et al. The consortium to establish a registry for Alzheimer's disease (CERAD). II. Standardisation of the neuropathological assessment of Alzheimer's disease. Neurology 1991: 41; 479-486.
22. Armstrong RA. β-amyloid (Aβ) deposition in elderly non-demented patients and patients with Alzheimer's disease. Neurosci. Lett. 1994; 178; 59-62.
23. Armstrong RA. β-amyloid deposition in the medial temporal lobe in elderly non-demented brains and in Alzheimer's disease. Dementia 1995; 6; 121-125.
24. Dickson DW, Ruan D. Crystal H et al. Hippocampal degeneration differentiates diffuse Lewy body disease (DLBD) from Alzheimer's disease: light and electron microscope immunocytochemistry of CA2-3 neurites specific to DLBD. Neurology 1991; 41; 1402-1409.
25. Gibb WRG, Luthert PJ, Janota I, Lantos PL. Cortical Lewy body dementia: clinical features and classification. J. Neurol. Neurosurg. Psychiatr. 1989; 52; 185-192.
26. Cummings BJ, Cotman CW. Image analysis of β-amyloid load in Alzheimer's disease and relation to dementia severity. Lancet 1995; 346; 1524-1528.
27. Schultz-Schaeffer WJ, Giese A, Windl O, Kretschmar HA. Polymorphism at codon 129 of the prion protein gene determines cerebellar pathology in Creutzfeldt-Jakob disease. Clin. Neuropathol. 1996: 15; 353-357.
28. Armstrong RA, Lantos PL, Cairns NJ. Quantification of the pathological changes with laminar depth in the cortex in sporadic Creutzfeldt-Jakob disease. Pathophysiol. 2001: 8; 99-104.
29. Armstrong RA. The usefulness of spatial pattern analysis in understanding the pathogenesis of neurodegenerative disorders, with particular reference to plaque formation in Alzheimer's disease. Neurodegen. 1993; 2; 73-80.
30. Armstrong RA. Analysis of spatial patterns in histological sections of brain tissue. J. Neurol. Sci. Meth. 1997; 73; 141-147.
31. Armstrong RA, Cairns NJ, Lantos PL. Spatial distribution of diffuse, primitive and classic amyloid-β deposits and blood vessels in the upper laminae of the frontal cortex in Alzheimer's disease. Alz. Dis. Assoc. Disord. 1998: 12; 378-383.
32. Cairns NJ, Chadwick A, Luthert PJ. Lantos PL. β-amyloid load is relatively uniform throughout neocortex and hippocampus in elderly Alzheimer disease patients. Neurosci. Lett. 1991: 129; 115-118.
33. Armstrong RA, Nochlin D, Bird TD. Neuropathological heterogeneity in Alzheimer's disease: a study of 80 cases using principal components analysis. Neuropathol 2000: 20; 1-37.
34. Brower JE, Zar JH, von Ende CN. Field and laboratory methods for general ecology. Dubuque, IA: Wm. C. Brown. 1990.
35. Duyckaerts C, Hauw JJ, Bastenaire F et al. Laminar distribution of neocortical senile plaques in senile dementia of the Alzheimer type. Acta Neuropathol. 1986: 70: 249-256.
36. Hof PR, Morrison JH. Quantitative analysis of a vulnerable subset of pyramidal neurons in Alzheimer's disease: II. Primary and secondary visual cortex. J. Comp. Neurol. 1990; 301; 55-64.
37. DeLacoste M, White CL. The role of cortical connectivity in Alzheimer's disease pathogenesis: a review and model system. Neurobiol. Aging 1993; 14; 1-16.
38. Armstrong RA. Analysis of population dispersion in histological sections. Microscopy Anal. 2001: 86; 13-15.
39. Snedecor GW, Cochran WG. Statistical methods. Ames. IA: Iowa State University Press, 1980.
40. Hardy JA, Higgins GA. Alzheimer's disease: the amyloid cascade hypothesis. Science 1992; 256; 184-185.
41. Mann DMA, Jones D. Deposition of amyloid A4 protein within the brains of persons with dementing disorders other than Alzheimer's disease and Down's syndrome. Neurosci. Lett. 1990: 109; 68-75.
42. Delaere P, He Y, Fayet G et al. βA4 deposits are constant in the brain of the oldest old: an immunocytochemical study of 20 French centenarians. Neurobiol. Aging 1993; 14; 191-194.
43. Corio F, Moreno A, Rubio I et al. The cellular pathology associated with Alzheimer β-amyloid deposits in non-demented aged individuals. Neuropathol. Appl. Neurol. 1993; 19; 261-268.
44. Jellinger KA, Bancher C. Neuropathology of Alzheimer's disease: a critical update. J. Neural. Transm. 1998; 54; 77-95.
45. Armstrong RA, Slade SV, Eperjesi F. An introduction to analysis of variance (ANOVA) with special reference to clinical experiments in optometry. Ophthal. Physiol. Opt. 2000: 20; 235-241.
46. Armstrong RA, Eperjesi F, Gilmartin B. The application of analysis of variance to different experimental designs in optometry. Ophthal. Physiol. Opt. 2002; 22; 248-256.
47. Forstl H, Fischer P. Diagnostic confirmation, severity, and subtypes of Alzheimer's disease: a short review on clinicopathological correlations. Eur. Arch. Psychiatr. Clin. Neurosci. 1994: 244; 252-260.
48. Pielou EC. An introduction to mathematical ecology. New York: John Wiley, 1967.
49. Ritchie K, Touchon J. Heterogeneity in senile dementia of the Alzheimer type: individual differences, progressive deterioration or clinical subtypes? J. Clin. Epidemiol. 1992: 45; 1391-1398.
50. Duyckaerts C, Colle MA, Delatour B, Hauw JJ. Alzheimer's disease: lesions and their progression. Rev. Neurologique 1999: 155; 4517-4527.
51. Trojanowski JQ, Clark CM, Schmidt ML, Arnold SE, Lee VMY. Strategies for improving the postmortem neuropathological diagnosis of Alzheimer's disease. Neurobiol. Aging 1997: 18; S75-S79.